Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer

NCT03225989 is registered in ClinicalTrials.gov with Lokon Pharma AB as lead sponsor.

NCT NCT03225989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03225989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer
Lead sponsor
Lokon Pharma AB
Phase
Phase 1/2
Overall status
Completed
Start date
March 1, 2018
Completion date
August 22, 2023
Enrollment
47 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

biliary carcinoma, colorectal cancer, ovarian cancer, pancreatic adenocarcinoma